CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 23/06/2024 BST			5-day change	1st Jan Change
4.923 ^DKK	-3.25%		-3.03%	+5.12%

06-17	CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	MT
06-12	CS Medica to Boost Denmark Operations With OneMed Partnership	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about CS MEDICA A/S

CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	06-17	MT
CS Medica to Boost Denmark Operations With OneMed Partnership	06-12	MT
CS MEDICA Announces Strategic Partnership with OneMed	06-12	CI
CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership	06-11	MT
CS Medica A/S Announces Strategic Expansion Through Innovation and Collaboration	06-11	CI
CS Medica Advances Spin-off, Listing Plans in Germany for Cannordic Unit	06-10	MT
CS Medica A/S agreed to Spin-Off Cannordic A/S.	06-09	CI
Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	05-23
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02-02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	01-26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	12-27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	12-05
CS Medica A/S Announces Financial Year Change	11-22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	11-22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/10/23	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/10/23	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/10/23	CI

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar